In these studies, EV-TF activity consistently predicted worse survival outcome, which is a surrogate parameter for advanced tumor stage and high tumor grade [28,29], and EV-TF activity was highly elevated in patients with poorly differentiated metastatic pancreatic cancer [18]. The gene discussed is TF; the disease is neoplasm.